FDA Inspection
Medlife Pharmacy and CompoundingMedlife Pharmacy and Compounding – FDA Inspection, Apr 18, 2018
Record Details
This FDA Inspection record concerns Medlife Pharmacy and Compounding, with an inspection on April 18, 2018, issued by the Los Angeles District Office, covering human drugs.
View Company Profile
ID · a9291511-adfb-4097-ab66-8bc0e4095063
Inspection Facts
- Inspection number
- 1048680
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Medlife Pharmacy and Compounding
1| Date | Classification | Office | Project area |
|---|---|---|---|
| June 15, 2021 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Medlife Pharmacy and Compounding
- FDA Inspection 1144689 - 2021-06-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.